SIA
LH icon

Soltis Investment Advisors’s Labcorp LH Stock Holding History

Soltis Investment Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,428
Closed -$878K – 223
2020
Q3 		$878K Buy
5,428
+439
+9% +$69.6K 0.21% 87
2020
Q2 		$712K Buy
+4,989
New +$690K 0.18% 88

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Soltis Investment Advisors's LH Position: Q4 2020 in Review

Soltis Investment Advisors sold out of Labcorp (LH) in Q4 2020, closing a stake of 5,428 shares — an estimated $878K sold.

Soltis Investment Advisors first reported a position in LH in Q2 2020 and held it in 2 quarters. The position peaked at $878K in Q3 2020. 906 funds tracked by Wall St. Rank hold LH as of Q4 2020.

  • Soltis Investment Advisors reported no remaining Labcorp position as of Q4 2020 after selling out during the quarter.
  • Soltis Investment Advisors sold 5,428 Labcorp shares in Q4 2020, an estimated $878K.
  • Soltis Investment Advisors first reported a position in Labcorp in Q2 2020 and held it in 2 quarters.
  • Soltis Investment Advisors's Labcorp position peaked at $878K in Q3 2020.
  • 906 funds tracked by Wall St. Rank held Labcorp as of Q4 2020.

Based on Soltis Investment Advisors's 13F filing for Q4 2020, filed 10 Feb 2021.